KRAS and cancer: Additionally, while the described studies specifically identify a requirement for Cdc42 in HRasV12-driven transformation, how Cdc42 might affect transformation resulting from the activation of other Ras proteins (i.e. KRAS and NRAS) commonly activated in human cancers remains to be explored.